跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMOXICILINA/ACIDO CLAVULANICO SANDOZ 100 MG/ML + 12,5 MG/ML POLVO PARA SUSPENSION ORAL EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AMOXICILINA/ACIDO CLAVULANICO SANDOZ 100 MG/ML + 12,5 MG/ML POLVO PARA SUSPENSION ORAL EFG
Approved
STANDARD
AMOXICILINA/ACIDO CLAVULANICO SANDOZ 100 MG/ML + 12,5 MG/ML POLVO PARA SUSPENSION ORAL EFG
Sandoz Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 22, 2024
Approval ID
742d1abf65e1c74f
Company
Sandoz Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
742d1abf65e1c74f
Drug Cima Aemps Name
AMOXICILINA/ACIDO CLAVULANICO SANDOZ 100 MG/ML + 12,5 MG/ML POLVO PARA SUSPENSION ORAL EFG
Register Number
89514
Holder Company Name
Sandoz Farmaceutica S.A.
Marketing Company Name
Sandoz Farmaceutica S.A.
Authorization Date
2024-04-22
Dosage Form
POLVO PARA SUSPENSIÓN ORAL
Dose
100 mg/ml + 12,5 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Sandoz Farmaceutica S.A.
Active Ingredients
AMOXICILINA TRIHIDRATO
110,78 - 123,12 mg/ml
CLAVULANATO POTASIO
14,67-15,50 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 22, 2024
Approval ID
742d1abf65e1c74f
Type
Standard
Back to CIMA-AEMPS Approvals